OUR TECHNOLOGICAL STRENGTHS
A COMPLETE RANGE OF ADVANCED TECHNOLOGICAL PLATFORMS:
In order to accelerate accurate drug candidate selection in a shorter cycle time with reduced risk, Genfit has optimized a range of parallel platforms to address internal and collaborative research efforts:
PRIVILEGED ACCESS TO KEY BIOLOGICAL TISSUES AND PRIMARY CELLS:
Genfit is situated at the heart of France’s leading medical hub, Eurasanté, the country’s foremost healthcare bioincubator. This privileged location, in addition to close collaboration with a range of academic institutions, provides us with access to a large range of valuable differentiated and primary human cells, tissues and samples which are used in a strict ethical and quality framework.
KNOW MORE ABOUT OUR TECHNOLOGIES
Please click on our technology fact sheets to see examples of the wide range of biological samples and assays in our key areas of expertise. Contact us for further information related to our technologies.
Scientific and Technical Capacities in Cardiovascular DiseaseScientific and Technical Capacities Dyslipidemia and HypertensionScientific and Technical Capacities in Obesity and DiabetesScientific and Technical Capacities in InflammationScientific and Technical Capacities in Nuclear Receptors
INFRASTRUCTURE TO PROTECT RESEARCH AND DEVELOPMENT:
Genfit has implemented a comprehensive quality and IT framework. An optimal level of quality assurance is essential to fulfill the industry requirements of pharmaceutical research and development. In the context of proprietary drug development and partner collaboration, Genfit embraces industry reference standards such as GLPs, GCPs and GBEA, as well as adhering to national and European legislation.
